Dickfeld Timm, Lei Peng, Dilsizian Vasken, Jeudy Jean, Dong Jun, Voudouris Apostolos, Peters Robert, Saba Magdi, Shekhar Raj, Shorofsky Stephen
Division of Cardiology, University of Maryland, Baltimore, Maryland 21201, USA.
JACC Cardiovasc Imaging. 2008 Jan;1(1):73-82. doi: 10.1016/j.jcmg.2007.10.001.
This study sought to assess the feasibility of deriving 3-dimensional (3D) scar maps from positron emission tomography (PET)/computed tomography (CT) hybrid imaging and to integrate those into clinical mapping systems to assist in ventricular tachycardia (VT) ablations.
Ablation strategies for nonidiopathic VT are increasingly based on the anatomic information of the scar and its border zone. However, the current "gold standard" of voltage mapping is limited by its inability to accurately describe a complex 3D scar morphology, its imperfect spatial resolution, and prolonged procedure times.
Fourteen patients underwent PET/CT multimodality imaging before the VT ablation. We used PET/CT-derived scar maps to characterize myocardial scar using a 17-segment analysis and surface reconstruction. In 10 patients, reconstructed 3D metabolic scar maps were integrated into a clinical mapping system and compared with high-resolution voltage maps.
A good correlation was found between the voltage maps and PET/CT-derived scar maps (r = 0.89; r < 0.05). In addition, 3D metabolic scar maps accurately displayed endocardial and epicardial surface and could be successfully integrated with a registration error of 3.7 +/- 0.7 mm. A combination of visual alignment and surface registration was most accurate for myocardial scar accounting for </=15% of the left ventricular surface. Scar size, location, and border zone accurately predicted high-resolution voltage map findings (r = 0.87; p < 0.05). Integrated scar maps revealed metabolically active channels within the myocardial scar not detected by voltage mapping and correctly predicted non-transmural scar despite normal endocardial voltage recordings. Areas of low voltage within wall segments displaying preserved metabolic activity were shown to be due to suboptimal catheter contact and prevented unnecessary ablation lesions.
We found that PET/CT fusion imaging is able to accurately assess left ventricular scar and its border zone. The integration of a 3D scar map into a clinical mapping system is feasible and may allow supplementary scar characterization that is not available from voltage maps. This technique could significantly facilitate substrate-based VT ablations.
本研究旨在评估从正电子发射断层扫描(PET)/计算机断层扫描(CT)混合成像中获取三维(3D)瘢痕图并将其整合到临床标测系统以辅助室性心动过速(VT)消融的可行性。
非特发性VT的消融策略越来越多地基于瘢痕及其边界区的解剖信息。然而,当前电压标测的“金标准”受到其无法准确描述复杂的三维瘢痕形态、空间分辨率不完善以及手术时间延长的限制。
14例患者在VT消融术前接受了PET/CT多模态成像。我们使用PET/CT衍生的瘢痕图通过17节段分析和表面重建来表征心肌瘢痕。在10例患者中,将重建的三维代谢瘢痕图整合到临床标测系统中,并与高分辨率电压图进行比较。
电压图与PET/CT衍生的瘢痕图之间存在良好的相关性(r = 0.89;r < 0.05)。此外,三维代谢瘢痕图准确显示了心内膜和心外膜表面,并能以3.7±0.7 mm的配准误差成功整合。视觉对齐和表面配准相结合对于占左心室表面≤15%的心肌瘢痕最为准确。瘢痕大小、位置和边界区准确预测了高分辨率电压图的结果(r = 0.87;p < 0.05)。整合的瘢痕图显示了电压标测未检测到的心肌瘢痕内的代谢活跃通道,并正确预测了尽管心内膜电压记录正常但存在的非透壁瘢痕。壁段内代谢活性保留但电压较低的区域显示是由于导管接触不佳所致,从而避免了不必要的消融损伤。
我们发现PET/CT融合成像能够准确评估左心室瘢痕及其边界区。将三维瘢痕图整合到临床标测系统是可行的,并且可能允许进行电压图无法提供的补充性瘢痕表征。该技术可显著促进基于基质的VT消融。